Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative Use of Dexmedetomidine-esketamine Combination and Transcranial Direct Current Stimulation for Prevention of Neurocognitive Complications in Older Patients After Non-cardiac Surgery: a 2×2 Factorial Trial

NCT07576517 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07576517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07576517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative Use of Dexmedetomidine-esketamine Combination and Transcranial Direct Current Stimulation for Prevention of Neurocognitive Complications in Older Patients After Non-cardiac Surgery: a 2×2 Factorial Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
December 31, 2030
Enrollment
1,996 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, esketamine, older patients, perioperative neurocognitive disorders, surgery, transcranial direct current stimulation